These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16979342)

  • 21. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
    Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
    J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
    Li W; Xia L; Hu A; Liu A; Peng J; Tan W
    Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
    J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
    Sun J; Mei H
    Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.
    Chand P; Babu YS; Bantia S; Rowland S; Dehghani A; Kotian PL; Hutchison TL; Ali S; Brouillette W; El-Kattan Y; Lin TH
    J Med Chem; 2004 Apr; 47(8):1919-29. PubMed ID: 15055992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
    Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
    Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
    J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
    Lew W; Wu H; Mendel DB; Escarpe PA; Chen X; Laver WG; Graves BJ; Kim CU
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3321-4. PubMed ID: 9873727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine-piperazine conjugates as potent influenza neuraminidase blocker.
    Enkhtaivan G; Kim DH; Park GS; Pandurangan M; Nicholas DA; Moon SH; Kadam AA; Patel RV; Shin HS; Mistry BM
    Int J Biol Macromol; 2018 Nov; 119():1204-1210. PubMed ID: 30099043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
    Krueger AC; Xu Y; Kati WM; Kempf DJ; Maring CJ; McDaniel KF; Molla A; Montgomery D; Kohlbrenner WE
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1692-5. PubMed ID: 18242993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
    Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
    Li ZS; Sun JY; Liang GZ; Lu FL; Zhu WP; Zhang MJ; Zhang Y; Yang SB; Shu M; Chen GH; Lu TT
    Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors.
    Orjales A; Mosquera R; López B; Olivera R; Labeaga L; Núñez MT
    Bioorg Med Chem; 2008 Mar; 16(5):2183-99. PubMed ID: 18158247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.